Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.tips.2014.04.011 http://scihub22266oqcxt.onion/10.1016/j.tips.2014.04.011 C4108072!4108072!24881011     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24881011&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Trends+Pharmacol+Sci 2014 ; 35 (7): 349-57 Nephropedia Template TP {{tp|p=24881011|t=2014. The therapeutic value of targeting inflammation in gastrointestinal cancers |pdf=|usr=}}{{24881011}} gab.com Text The therapeutic value of targeting inflammation in gastrointestinal cancers JO: Trends Pharmacol Sci http://www.kidney.de/pget.php?&tw=1&pmid=24881011 #FOAvip Inflammation has been implicated in the initiation and progression of gastrointestinal (GI) cancers. Inflammation also plays important roles in subverting immune tolerance, escape from immune surveillance, and conferring resistance to chemotherapeutic agents. Targeting key regulators and mediators of inflammation represents an attractive strategy for GI cancer prevention and treatment. However, the targeting of inflammation in GI cancer is not straight-forward and sometimes inflammation may contribute to tumor regression. We discuss the origins and effects of inflammation in GI cancer and how to target it successfully. Twit Text FOAVip The therapeutic value of targeting inflammation in gastrointestinal cancers ????Trends Pharmacol Sci http://www.kidney.de/pget.php?&tw=1&pmid=24881011 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24881011 #FOAvip English Wikipedia <ref>{{Cite pmid|24881011}}</ref> The therapeutic value of targeting inflammation in gastrointestinal cancers #MMPMID24881011 Sun B; Karin M Trends Pharmacol Sci 2014[Jul]; 35 (7): 349-57 PMID24881011show ga Inflammation has been implicated in the initiation and progression of gastrointestinal (GI) cancers. Inflammation also plays important roles in subverting immune tolerance, escape from immune surveillance, and conferring resistance to chemotherapeutic agents. Targeting key regulators and mediators of inflammation represents an attractive strategy for GI cancer prevention and treatment. However, the targeting of inflammation in GI cancer is not straight-forward and sometimes inflammation may contribute to tumor regression. We discuss the origins and effects of inflammation in GI cancer and how to target it successfully. äThe therapeutic value of targeting inflammation in gastrointestinal ca(epmc).pdf DeepDyve Pubget Overpricing